Add to Basket
Order hotline:
+1 404 474 4654
+1 888 205 9894 (TF)

Exocyst Complex Component 4 (EXOC4) (N-Term) antibody

Antigen

Exocyst Complex Component 4 (EXOC4)

Synonyms REC8, SEC8, Sec8p, SEC8L1, MGC27170, Sec8, C78892, Sec8l1, MGC160074, si:rp71-18a24.2, si:ch211-92l17.2, ATSEC8, subunit of exocyst complex 8, SUBUNIT OF EXOCYST COMPLEX 8, DKFZp459N1430
Epitope

N-Term

Clonality Polyclonal
Host
Alternatives

Rabbit

Application
Alternatives Immunohistochemistry (IHC), Western Blotting (WB)
5 references available
Catalog no. ABIN350317
Quantity 100 µl
Price 413.33 $   Plus shipping costs $35.00
Shipping to
Availability Ships within 7 to 10 Business Days

Additional Information

Alternative name Exocyst complex component 4 (EXOC4, SEC8, SEC8 L1) (n-terminal)
Swiss-Prot Q96A65
Immunogen A synthetic peptide from the n-terminal of human Exocyst complex component 4 (EXOC4, SEC8, SEC8 L1) conjugated to an immunogenic carrier protein was used as the immunogen. The immunogen is homologous in mouse and rat.
Format Lyophilized
Description FUNCTION: Component of the exocyst complex involved in the docking of exocystic vesicles with fusion sites on the plasma membrane. SUBUNIT: The exocyst complex is composed of EXOC1, EXOC2, EXOC3, EXOC4, EXOC5, EXOC6, EXOC7 and EXOC8. Also known as: Exocyst complex component Sec8, SEC8, SEC8 L1, EXOC4.
Specificity Appears to be specific for EXOC4.

Application Details

Application Notes IHC, WB. A dilution of 1 : 300 to 1 : 2000 is recommended. The optimal dilution should be determined by the end user. Not yet tested in other applications.
Purity whole serum
Storage Maintain the lyophilised/reconstituted antibodies frozen at -20°C for long term storage and refrigerated at 2-8°C for a shorter term. When reconstituting, glycerol (1:1) may be added for an additional stability. Avoid freeze and thaw cycles.
Restrictions For Research Use only

Publications

Publications Nagase, Kikuno, Hattori et al.: "Prediction of the coding sequences of unidentified human genes. XIX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro." in: DNA research : an international journal for rapid publication of reports on genes and genomes, Vol. 7, Issue 6, pp. 347-55, 2001 (PubMed).

Ota, Suzuki, Nishikawa et al.: "Complete sequencing and characterization of 21,243 full-length human cDNAs." in: Nature genetics, Vol. 36, Issue 1, pp. 40-5, 2003 (PubMed).

Sjoeblom, Jones, Wood et al.: "The consensus coding sequences of human breast and colorectal cancers." in: Science (New York, N.Y.), Vol. 314, Issue 5797, pp. 268-74, 2006 (PubMed).

Beausoleil, Villuen, Gerber et al.: "A probability-based approach for high-throughput protein phosphorylation analysis and site localization." in: Nature biotechnology, Vol. 24, Issue 10, pp. 1285-92, 2006 (PubMed).

Dephoure, Zhou, Villuen et al.: "A quantitative atlas of mitotic phosphorylation." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 105, Issue 31, pp. 10762-7, 2008 (PubMed).

Alternatives

Alternatives for antigen "Exocyst Complex Component 4 (EXOC4)", type "Antibodies"
Hosts Mouse (3), Rabbit (2)
Reactivities Human (3)
Applications Western Blotting (WB) (5), Enzyme Immunoassay (EIA) (2), ELISA (1)